This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of the influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2021–2022 season. Influenza vaccination is an important intervention to protect vulnerable populations and reduce the burden of respiratory illnesses during circulation of severe acute respiratory syndrome coronavirus 2, which is expected to continue during this influenza season. In this technical report, we summarize recent influenza seasons, morbidity and mortality in children, vaccine effectiveness, vaccination coverage, and detailed guidance on storage, administration, and implementation. We also provide background on inactivated and live attenuated influenza vaccine recommendations, vaccination during pregnancy and breastfeeding, diagnostic testing, and antiviral medications for treatment and chemoprophylaxis.

本技术报告附有美国儿科学会关于在 2021-2022 年流感季节常规使用流感疫苗和抗病毒药物预防和治疗儿童流感的建议。流感疫苗接种是一项重要的干预措施，可在严重急性呼吸系统综合症冠状病毒 2 传播期间保护弱势人群并减轻呼吸道疾病负担，预计在本流感季节将继续传播。在这份技术报告中，我们总结了最近的流感季节、儿童的发病率和死亡率、疫苗有效性、疫苗接种覆盖率以及有关储存、管理和实施的详细指导。我们还提供有关灭活和减毒活流感疫苗建议的背景，